1Fröhlich H, Katus HA, Täger T, et al. Peritoneal ultrafiltration in end-stage chronic heart failure[J].Clin Kidney J. 2015,8(2):219-225. 2Teitelbaum I.Ultrafiltration failure in peritoneal dialysis: a pathophysiologic approach[J].Blood Purif. 2015,39(1-3):70-73. 3Szeto CC, Chan GC, Ng JK, et al. Depression and Physical Frailty Have Additive Effect on the Nutritional Status and Clinical Outcome of Chinese Peritoneal Dialysis[J].Kidney Blood Press Res. 2018,43(3):914-923. 4Johansson L.Nutrition in Older Adults on Peritoneal Dialysis[J].Perit Dial Int. 2015 ,35(6):655-8. 5娄丽璇,俞雨生.不同腹膜透析液的特点及临床应用评价[J].肾脏病与透析肾移植杂志.2016,25(2):186-188. 6Vaios V, Georgianos PI, Liakopoulos V, et al. Assessment and Management of Hypertension among Patients on Peritoneal Dialysis[J]. Clin J Am Soc Nephrol. 2018 Oct 19. pii: CJN.07480618. doi: 10.2215/CJN.07480618. 7Bajo MA, Del Peso G, Teitelbaum I.Peritoneal Membrane Preservation[J]. Semin Nephrol. 2017,37(1):77-92. 8Krediet RT.Ultrafiltration Failure Is a Reflection of Peritoneal Alterations in Patients Treated With Peritoneal Dialysis[J]. Front Physiol. 2018,9:1815. doi: 10.3389/fphys.2018.01815. 9Teitelbaum I. Ultrafiltration failure in peritoneal dialysis: a pathophysiologic approach[J]. Blood Purif. 2015,39(1-3):70-73. 10Stachowska-Pietka J, Poleszczuk J, Flessner MF, et al. Alterations of peritoneal transport characteristics in dialysis patients with ultrafiltration failure: tissue and capillary components[J].Nephrol Dial Transplant. 2018 Nov 6. doi: 10.1093/ndt/gfy313. 11Stachowska-Pietka J, Poleszczuk J, Flessner MF, et al.Alterations of peritoneal transport characteristics in dialysis patients with ultrafiltration failure: tissue and capillary components[J] Nephrol Dial Transplant. 2018 Nov 6. doi: 10.1093/ndt/gfy313. 12Weryński A, Waniewski J, Wang T, et al. Comparison of kinetic characteristics of amino acid-based and dipeptide-based peritoneal dialysis solutions[J]. Int J Artif Organs. 2006,29(7):681-690. 13Lindholm B, Park MS, Bergström J.Supplemented dialysis: amino acid-based solutions in peritoneal dialysis[J].Contrib Nephrol. 1993,103:168-82. 14孙玉玲,Susan Yung,余学清,et al.氨基酸腹膜透析液与传统腹膜透析液对腹膜间皮细胞功能的影响[J].中华肾脏病杂志.2004,20(1):37-41. 15Trottier C, Perl J, Freeman M, et al. Protein Carbamylation in Peritoneal Dialysis and the Effect of Low Glucose Plus Amino Acid Solutions[J]. Perit Dial Int. 2018,38(2):149-152. 16Amici G, Bergia R, Cancarini G,et al. Prescription in peritoneal dialysis[J]. J Nephrol. 2013, 26 Suppl 21:83-95. 17Ma?gorzewicz S, Heleniak Z, Lichodziejewska-Niemierko M, et al.Protein-energy wasting and asymmetric dimethylarginine in peritoneal dialysis patients[J].Acta Biochim Pol. 2018, 65(4):581-584. 18王军, 贾忠辉, 俞雨生.氨基酸腹膜透析液在腹膜透析营养不良患者中的应用前景[J].医学研究生学报.2004,17(6):554-557. 19Gjessing J. 0Addition of aminoacids to peritoneal-dialysis fluid[J]. Lancet. 1968,12;2(7572):812. 20Reimann D, Dachs D, Meye C, et al. Amino acid-based peritoneal dialysis solution stimulates mesothelial nitric oxide production[J]. Perit Dial Int. 2004,24(4):378-384. 21庞慧华,倪兆慧,钱家麒.新型腹膜透析液的临床应用[J].中国血液净化.2010,9(8):454-456.
|